Allex


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
immunity, hardy kiwi extract, immune hypersensitivity
Category
Health Care Supplement
tK Meet
tK Meet

Apply a video call to the Supplier

SEND TO SUPPLIER INQUIRY

ViroMed

Membership
VIP
Country / Year Established
South Korea South Korea / 1996
Business type
Manufacturer
Verified Certificate

10

DUNS

Product name Allex Certification -
Category Health Care Supplement Ingredients -
Keyword immunity , hardy kiwi extract , immune hypersensitivity Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

Allex

Nutraceutical for Allergies and Allergic Disease 

 



 

 

 

 

│ DESCRIPTION │ 

 

 

Allex is a functional food product made with hardy kiwi extract as the main ingredient. Allex was developed to help those suffering from immune hypersensitivity and is successfully marketed in Korea.

 

 

Allex is the first product to receive approval for ‘help improve immune hypersensitivity’ functional claim from the KFDA. Results from human trial have already been published in an international scientific journal and patents have been issued from 14 different countries. 

 

The human trial for hardy kiwi extract, conducted at Seoul National University Hospital, showed improvements in various immune hypersensitivity related markers (IgE, ECP, eotaxin, etc.) and was able to complete KFDA’s functionality evaluation with it.  

 

 

 



│ CLINICAL TRIAL │

 

 

The ability of hardy kiwi extract (PG102) to improve hyper-immune reactions was verified through clinical trials run by Korea’s leading researchers at Seoul National University Hospital’s Division of Allergy and Clinical Immunology.  

 

Name of trial: Effect of Edible Actinidia arguta Extract (PG102) on Allergy-Related Primary Risk Factors.(randomized, double-blind, placebo comparison)  

 

Locations of trial: Division of Allergy and Clinical Immunology at Seoul National University Hospital and Bundang Hospital.  

 

Results of trial: PG102 had no observed side effects while safely improving allergy reaction levels. It was judged to have superior properties as a nutraceutical in controlling inflammation and fluids and inhibiting the advancement of immune reactions. 

 

 

 



│ FEATURES │

 

 

Product made with natural substance.  

 

Introduced as a new alternative for immune hypersensitivity.  

 

Selected as one of five functional food products good for immunity by KHSA. 



(Korea Health Supplements Association). 

 

 

 

│ HEALTH INFORMATION │

 

 

Immune hypersensitivity refers to body’s overreaction to substances such as pollen, yellow dust, cold wind, dust mite, smog, specific food, etc.  

  

Immune hypersensitivity can occur due to genetics or when exposed to causative substances while the immune system is overly sensitive due to environmental pollution.

Ex)Skin: Itchness/redness/hives, Respiratory: Dry cough/difficulty breathing, Nose: Runny nose/itchy nose/stuffy nose. 

 

26.8 % (2011) of Korean population are known to suffer from immune hypersensitivity. We have already been receiving inquiries regarding raw material/product from Thailand. 

 

Allex does not contain any artificial coloring or flavoring and does not have any known side effects, which makes it suitable for those wanting to improve immune hypersensitivity safely. 

 

Usage: 2 capsules, 2 times daily, with water

Specification: 120 caps/bottle.

Shelf Life: Two years

Storage: Keep in a dry and cool place.

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

ViroMed

Country / Year Established
South Korea South Korea / 1996
Membership
VIP
Business type
Manufacturer

10

DUNS

President
Yongsoo Kim
Address
#5, Bldg, 203, Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea
Product Category
Health Care Supplement,Skin Care Set
Year Established
1996
No. of Total Employees
51-100
Company introduction

 

ViroMed Co., Ltd. (ViroMed), a leading biopharmaceutical company focusing on the development of innovative medicine, was established in 1996 and is headquartered in Seoul, Korea with a US presence in Atlanta Area. ViroMed has been listed on the KOSDAQ stock exchange (084990) since 2005.

ViroMed has assembled a diverse pipeline of novel biologics and Botanical therapeutics in the areas of cardiovascular disease, cancer and immune disorder, with eight projects in clinical stages in the US, Korea, and China. The company has established several key partnerships with Reyon Pharm. (Korea), PMG Pharm. (Korea) and Beijing Northland Biotech (China).

The founder of ViroMed is Professor Sunyoung Kim of Seoul National University (SNU), who holds academic degrees from SNU, MIT, Harvard and Oxford, and also served as an assistant professor at Harvard Medical School and a postdoctoral fellow at MIT. Rallied under the leadership of Prof. Kim, experts from various fields have been united to achieve one goal to cure the incurables

 

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My tK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more